These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32447331)

  • 1. Retrospective evaluation of 85 patients with urea cycle disorders: one center experience, three new mutations.
    Saritaş Nakip Ö; Yıldız Y; Tokatlı A
    J Pediatr Endocrinol Metab; 2020 May; 33(6):721-728. PubMed ID: 32447331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urea cycle disorders in India: clinical course, biochemical and genetic investigations, and prenatal testing.
    Bijarnia-Mahay S; Häberle J; Jalan AB; Puri RD; Kohli S; Kudalkar K; Rüfenacht V; Gupta D; Maurya D; Verma J; Shigematsu Y; Yamaguchi S; Saxena R; Verma IC
    Orphanet J Rare Dis; 2018 Oct; 13(1):174. PubMed ID: 30285816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urea cycle disorders in Argentine patients: clinical presentation, biochemical and genetic findings.
    Silvera-Ruiz SM; Arranz JA; Häberle J; Angaroni CJ; Bezard M; Guelbert N; Becerra A; Peralta F; de Kremer RD; Laróvere LE
    Orphanet J Rare Dis; 2019 Aug; 14(1):203. PubMed ID: 31426867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical findings of patients with hyperammonemia affected by urea cycle disorders with hepatic encephalopathy.
    Lopes FF; Sitta A; de Moura Coelho D; Ribas GS; Faverzani JL; Dos Reis BG; Wajner M; Vargas CR
    Int J Dev Neurosci; 2022 Dec; 82(8):772-788. PubMed ID: 36129623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unfavorable clinical outcomes in patients with carbamoyl phosphate synthetase 1 deficiency.
    Choi Y; Oh A; Lee Y; Kim GH; Choi JH; Yoo HW; Lee BH
    Clin Chim Acta; 2022 Feb; 526():55-61. PubMed ID: 34973183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age at disease onset and peak ammonium level rather than interventional variables predict the neurological outcome in urea cycle disorders.
    Posset R; Garcia-Cazorla A; Valayannopoulos V; Teles EL; Dionisi-Vici C; Brassier A; Burlina AB; Burgard P; Cortès-Saladelafont E; Dobbelaere D; Couce ML; Sykut-Cegielska J; Häberle J; Lund AM; Chakrapani A; Schiff M; Walter JH; Zeman J; Vara R; Kölker S;
    J Inherit Metab Dis; 2016 Sep; 39(5):661-672. PubMed ID: 27106216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perspectives on urea cycle disorder management: Results of a clinician survey.
    Enns GM; Porter MH; Francis-Sedlak M; Burdett A; Vockley J
    Mol Genet Metab; 2019; 128(1-2):102-108. PubMed ID: 31377149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unraveling the Link: Seizure Characteristics and Ammonia Levels in Urea Cycle Disorder During Hyperammonemic Crises.
    Chanvanichtrakool M; Schreiber JM; Chen WL; Barber J; Zhang A; Ah Mew N; Schulze A; Wilkening G; Nagamani SCS; Gropman A;
    Pediatr Neurol; 2024 Oct; 159():48-55. PubMed ID: 39121557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urea cycle disorders in Spain: an observational, cross-sectional and multicentric study of 104 cases.
    Martín-Hernández E; Aldámiz-Echevarría L; Castejón-Ponce E; Pedrón-Giner C; Couce ML; Serrano-Nieto J; Pintos-Morell G; Bélanger-Quintana A; Martínez-Pardo M; García-Silva MT; Quijada-Fraile P; Vitoria-Miñana I; Dalmau J; Lama-More RA; Bueno-Delgado MA; Del Toro-Riera M; García-Jiménez I; Sierra-Córcoles C; Ruiz-Pons M; Peña-Quintana LJ; Vives-Piñera I; Moráis A; Balmaseda-Serrano E; Meavilla S; Sanjurjo-Crespo P; Pérez-Cerdá C
    Orphanet J Rare Dis; 2014 Nov; 9():187. PubMed ID: 25433810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical course of 63 patients with neonatal onset urea cycle disorders in the years 2001-2013.
    Unsinn C; Das A; Valayannopoulos V; Thimm E; Beblo S; Burlina A; Konstantopoulou V; Mayorandan S; de Lonlay P; Rennecke J; Derbinski J; Hoffmann GF; Häberle J
    Orphanet J Rare Dis; 2016 Aug; 11(1):116. PubMed ID: 27538463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severity-adjusted evaluation of newborn screening on the metabolic disease course in individuals with cytosolic urea cycle disorders.
    Posset R; Kölker S; Gleich F; Okun JG; Gropman AL; Nagamani SCS; Scharre S; Probst J; Walter ME; Hoffmann GF; Garbade SF; Zielonka M;
    Mol Genet Metab; 2020 Dec; 131(4):390-397. PubMed ID: 33288448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular diagnosis of urea cycle disorders: current global scenario.
    Vaidyanathan K
    Indian J Biochem Biophys; 2013 Oct; 50(5):357-62. PubMed ID: 24772957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adult-onset diagnosis of urea cycle disorders: Results of a French cohort of 71 patients.
    Toquet S; Spodenkiewicz M; Douillard C; Maillot F; Arnoux JB; Damaj L; Odent S; Moreau C; Redonnet-Vernhet I; Mesli S; Servais A; Noel E; Charriere S; Rigalleau V; Lavigne C; Kaphan E; Roubertie A; Besson G; Bigot A; Servettaz A; Mochel F; Garnotel R
    J Inherit Metab Dis; 2021 Sep; 44(5):1199-1214. PubMed ID: 34014557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severity-adjusted evaluation of initial dialysis on short-term health outcomes in urea cycle disorders.
    Zielonka M; Kölker S; Garbade SF; Gleich F; Nagamani SCS; Gropman AL; Druck AC; Ramdhouni N; Göde L; Hoffmann GF; Posset R;
    Mol Genet Metab; 2024; 143(1-2):108566. PubMed ID: 39299137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving long term outcomes in urea cycle disorders-report from the Urea Cycle Disorders Consortium.
    Waisbren SE; Gropman AL; ; Batshaw ML
    J Inherit Metab Dis; 2016 Jul; 39(4):573-84. PubMed ID: 27215558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infectious precipitants of acute hyperammonemia are associated with indicators of increased morbidity in patients with urea cycle disorders.
    McGuire PJ; Lee HS; ; Summar ML
    J Pediatr; 2013 Dec; 163(6):1705-1710.e1. PubMed ID: 24084106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of rare variants causing urea cycle disorders: A clinical, genetic, and biophysical study.
    Liu F; Bao LS; Liang RJ; Zhao XY; Li Z; Du ZF; Lv SG
    J Cell Mol Med; 2021 Apr; 25(8):4099-4109. PubMed ID: 33611823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and treatment of urea cycle disorder in Japan.
    Nakamura K; Kido J; Mitsubuchi H; Endo F
    Pediatr Int; 2014 Aug; 56(4):506-9. PubMed ID: 25039902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between longitudinal changes in neuropsychological outcome and disease biomarkers in urea cycle disorders.
    Lichter-Konecki U; Sanz JH; ; McCarter R
    Pediatr Res; 2023 Dec; 94(6):2005-2015. PubMed ID: 37454183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-sectional observational study of 208 patients with non-classical urea cycle disorders.
    Rüegger CM; Lindner M; Ballhausen D; Baumgartner MR; Beblo S; Das A; Gautschi M; Glahn EM; Grünert SC; Hennermann J; Hochuli M; Huemer M; Karall D; Kölker S; Lachmann RH; Lotz-Havla A; Möslinger D; Nuoffer JM; Plecko B; Rutsch F; Santer R; Spiekerkoetter U; Staufner C; Stricker T; Wijburg FA; Williams M; Burgard P; Häberle J
    J Inherit Metab Dis; 2014 Jan; 37(1):21-30. PubMed ID: 23780642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.